Submit RFI/RFP
Request Consultation
Featured UK Leads the Way in Safe AI For Healthcare
On 24 June, the United Kingdom was the first country to join the HealthAI Global Regulatory Network, a new international initiative to ensure the safe and effective use…
Newsroom
News
300 articles
Featured 
Featured Breakthrough Stem Cell Therapy Offers New Hope for Blood Cancer Patients
Finding a treatment for hematological malignancies can be a challenging as it mainly depends on finding a suitable donor & if they are lucky enough to find a…
Featured FDA Raises Heat Safety Concerns Over Scopolamine Transdermal Patch
Scopolamine transdermal patches were approved by the FDA in the 1970s for managing nausea and vomiting caused by motion sickness; later, they also got FDA approval for recovery…
Featured FDA Greenlights New Triple Therapy For Relapsed Follicular Lymphoma
In a significant advancement for lymphoma treatment, the FDA has approved Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma (FL).…
Featured Turning Point in Cancer Care: NHS Unlocks Life-Saving Innovation
With continuous efforts to find new cancer treatments, comes to life a new ultrasound technology developed by a US based company called HistoSonics the device works by destroying…
Featured Inclusion Of Pregnant & Breastfeeding Women in Clinical Trials
The EMA has published a draft guideline for public consultation that offers recommendations on how to include and/or continue pregnant and breastfeeding individuals in clinical trials. The aim…
Featured Semaglutide Alert: Rare Eye Side Effect Identified
Non-arteritic anterior ischemic optic neuropathy, or NAION, is a very rare eye condition that causes vision loss; it affects 1 in 10,000 patients taking Semaglutide for treatment of…
Featured Accelerated Cancer Care with Advanced Radiotherapy
We now live in a time where innovation & technology are shaping our future from mobile phones to life saving inventions. The UK government has been investing in…
Featured Guselkumab has new approved indications for treating Crohn’s disease and ulcerative colitis patients
As of 16th of May 2025 Guselkumab (Tremfya) has been approved for the treatment of Crohn’s disease & Ulcerative colitis. However, it was initially used for the treatment…
Featured EMA Implements New Measures to Keep Antibiotic Resistance Under Control
With the rising risk of antibiotics resistance, EMA’s human medicines committee (CHMP) has decided on readjusting the use of some antibiotics like azithromycin and limiting its indications, in…
Featured FDA Embraces AI Future with Successful Pilot and Bold Expansion Plan
With the AI being integrated in almost everything nowadays, FDA has decided to dive in and also integrate AI in their practice. AI has proven to be an…
Featured Mental Health confirmed Risks in some Hair Loss Treatments
EMA’s safety committee, Pharmacovigilance Risk Assessment Committee (PRAC) recent review revealed negative mental health impact of finasteride and dutasteride on patients taking it for anti-hair loss purposes. Finasteride…
Featured Trixeo Aerosphere Inhaler Reformulated for A Cleaner Future
As part of global efforts to protect the environment, the Medicines and Healthcare products Regulatory Agency (MHRA) is playing a role by supporting changes to inhalers used by…
Featured New Breakthrough: FDA Approves New Blood Test for Early Diagnosis of Alzheimer’s
The FDA has just recently approved a new blood test called The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, that helps with the early detection of Alzheimer’s diseases in…
Featured Kaftrio Serious Impact on Mental health
With Kaftrio being used for treatment of patients with Cystic Fibrosis, comes serious negative impact on patient’s psychological state. As of 25 February 2025, the MHRA received 300…
Ready to simplify your journey?
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP